MindMaze

MindMaze étend et renforce son équipe de direction avec cinq nominations à des postes clés

MindMaze, un leader mondial sur le marché de la neurothérapie numérique (DTx) pour le rétablissement et les soins neu...

MindMaze

MindMaze Expands and Strengthens Global Leadership Team with Five Key Leadership Appointments

MindMaze, a global leader in digital therapeutics (DTx) for neurological recovery and care, today announced the appoi...

DTx West

Where does innovation need to occur within the industry to continue advancing digital therapeutics?

Our chief medical director Dr. John Krakauer joined other digital therapeutic experts at this year’s DTx West confere...

Empowered Patient Podcast

Using immersive Digital Therapeutic software to treat neurological diseases and injuries

Podcast host Karen Jagoda speaks to MindMaze Chief Medical Advisor Dr. John Krakauer about using immersive Digital Th...

MindMaze

MindMaze Secures $105 Million Financing, Led by Concord Health Partners, to Fund Growth on Heels of Banner Year and Initiates American Hospital Association Partnership

MindMaze (“the Company”), a global pioneer in the multibillion-dollar digital neurotherapeutics market, today announc...

MindMaze

MindMaze Powers Landmark Multidisciplinary Consortium to Develop State-of-the-Art Neuro-therapeutic Program Following Receipt of Prestigious CHF 5.9 Million Grant

SwissNeuroRehab, led by Lausanne University Hospital, to focus on developing a new model of neurorehabilitation treat...

MindMaze

MindMaze and Andretti Autosport: Driving the Future of Neurotechnology

MindMaze will continue its ground-breaking research into how its brain technology platform can boost safety and human...

MindMaze

Office Hours #3: How to find the perfect upper limb programme for your patient

Replay episode #3 of our ‘Office Hours with MindMaze’ series as we discuss how clinicians can find the perfect upper ...